These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21710803)

  • 1. What is in a name? A higher cost!
    Hansen KA
    S D Med; 2011 Jun; 64(6):194-5. PubMed ID: 21710803
    [No Abstract]   [Full Text] [Related]  

  • 2. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.
    Armstrong J
    N Engl J Med; 2011 May; 364(18):1689-91. PubMed ID: 21410391
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth.
    Calda P
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):540-2. PubMed ID: 19089768
    [No Abstract]   [Full Text] [Related]  

  • 4. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
    O'Brien JM
    Obstet Gynecol; 2012 Feb; 119(2 Pt 1):384-5; author reply 385-6. PubMed ID: 22270303
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

  • 6. Deus ex Makena?
    Silver RM; Cunningham FG
    Obstet Gynecol; 2011 Jun; 117(6):1263-1265. PubMed ID: 21471852
    [No Abstract]   [Full Text] [Related]  

  • 7. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH; Istwan NB; Rhea DJ; Smarkusky L; Hoffman MC; Stanziano GJ
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate.
    Bailit JL; Votruba ME
    Am J Obstet Gynecol; 2007 Mar; 196(3):219.e1-7. PubMed ID: 17346527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan economics: the downside of supplyside pharmacology.
    Samson K
    Ann Neurol; 2008 Sep; 64(3):A13-6. PubMed ID: 18825669
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives. Orphan Drug Act stumps lawmakers.
    Firshein J
    Faulkner Grays Med Health; 1990 Jun; 44(25):suppl 4 p.. PubMed ID: 10105023
    [No Abstract]   [Full Text] [Related]  

  • 11. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development.
    Engstrom LO
    Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295
    [No Abstract]   [Full Text] [Related]  

  • 12. Orphan drugs. Dutch situation is similar.
    Bouvy M
    BMJ; 2010 Dec; 341():c7018. PubMed ID: 21139005
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoption agent.
    Peota C
    Minn Med; 2005 Mar; 88(3):8-9. PubMed ID: 15852583
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals. Adopt an orphan.
    Karr A
    Health Serv J; 1999 Nov; 109(5681):28. PubMed ID: 10724720
    [No Abstract]   [Full Text] [Related]  

  • 15. View from the Nation's Capital.
    Freishtat HW
    J Clin Psychopharmacol; 1985 Apr; 5(2):117-9. PubMed ID: 3988970
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction-Current activities and future goals of orphan disease agencies.
    Van Woert MH
    Prog Clin Biol Res; 1985; 197():3-6. PubMed ID: 4070296
    [No Abstract]   [Full Text] [Related]  

  • 17. Deus ex Makena?
    Das AF; Birch R; Meis PJ
    Obstet Gynecol; 2011 Oct; 118(4):955; author reply 955-6. PubMed ID: 21934462
    [No Abstract]   [Full Text] [Related]  

  • 18. The European rare diseases therapeutic initiative.
    Fischer A; Borensztein P; Roussel C
    PLoS Med; 2005 Sep; 2(9):e243. PubMed ID: 16104832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug legislation. Drug companies divided.
    Gershon D
    Nature; 1990 May; 345(6270):6. PubMed ID: 2330052
    [No Abstract]   [Full Text] [Related]  

  • 20. [Orphan drugs--competing for a better name in Sweden].
    Karlsson Y
    Lakartidningen; 1990 Feb; 87(9):658. PubMed ID: 2308437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.